Raymond James Upgrades Kymera Therapeutics (KYMR) to Outperform, 'Improved Risk/Reward Setup'
Tweet Send to a Friend
(Updated - May 4, 2023 4:28 PM EDT)
Raymond James analyst Timur Ivannikov upgraded Kymera Therapeutics (NASDAQ: KYMR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Timur Ivannikov upgraded Kymera Therapeutics (NASDAQ: KYMR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
